Status:
COMPLETED
Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab)
Lead Sponsor:
GCS Ramsay Santé pour l'Enseignement et la Recherche
Conditions:
COVID
Eligibility:
MALE
18-65 years
Phase:
NA
Brief Summary
The objective of this study is to look for the presence of SARS-CoV-2 in the semen of patients diagnosed with COVID+ based on RT-PCR analysis of nasopharyngeal swabs.
Detailed Description
This is a prospective monocentric, open-label, prospective study of male patients with CoV-2-SARS.
Eligibility Criteria
Inclusion
- Male patient between the ages of 18 and 65 who has read and signed the consent form for participation in the study.
- Outpatient or inpatient without signs of respiratory severity, likely to be mobile
- Patient whose medical condition warrants screening for COVID-19 by nasopharyngeal swab
Exclusion
- Patient under protective custody, guardianship or trusteeship
- Patient not affiliated to the French social security system
- Inability to provide the subject with informed information and/or written informed consent: dementia, psychosis, consciousness disorders, non-French speaking patient
Key Trial Info
Start Date :
May 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 12 2021
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04460534
Start Date
May 7 2020
End Date
May 12 2021
Last Update
August 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé de Parly II
Le Chesnay, France, 78150